Yes, short-term GLP-1 use is generally safe when prescribed and monitored appropriately
Our 503B pharmacy partners: Are registered with the FDA and subject to scheduled federal inspections Operate under current Good Manufacturing Practice (cGMP) standards Maintain ISO-classified cleanroom environments for sterile compounding Employ full-time quality assurance and quality control teams Source active pharmaceutical ingredients from FDA-registered suppliers with documented Certificates of Analysis Report adverse events to the FDA as required We regularly evaluate our pharmacy partnerships and conduct our own due diligence on facility quality, compliance history, and testing protocols
Research-use framing: Material sold as cagrilintide is for laboratory and research purposes only and is not a medicine
Strong safety profile
The information contained herein is not intended to replace or substitute for conventional medical care or encourage its abandonment.
When combined with peptides such as MOTS-c, SS-31, or NAD+, it offers a comprehensive research model for studying anti-aging mechanisms, mitochondrial protection, and energy system preservation
